Search research articles
Contact Us
Filters
Showing results (51-60 of 178) with videos related to
Page
of 18
Sort By:
The American Journal of Medicine
|
December 1, 1985
Primary systemic amyloidosis. Comparison of melphalan/prednisone versus colchicine
R A Kyle, P R Greipp, J P Garton, et al.
British Journal of Haematology
|
February 23, 1999
Measurement of apoptosis and proliferation of bone marrow plasma cells in patients with plasma cell proliferative disorders
T E Witzig, M Timm, D Larson, et al.
Cytometry
|
November 1, 1985
A monoclonal antibody reactive with 5-bromo-2-deoxyuridine that does not require DNA denaturation
N J Gonchoroff, P R Greipp, R A Kyle, et al.
British Journal of Haematology
|
June 1, 1994
Detection of peripheral blood plasma cells as a predictor of disease course in patients with smouldering multiple myeloma
T E Witzig, R A Kyle, W M O'Fallon, et al.
Cancer
|
July 1, 1993
Quantitation of circulating peripheral blood plasma cells and their relationship to disease activity in patients with multiple myeloma
T E Witzig, M V Dhodapkar, R A Kyle, et al.
The New England Journal of Medicine
|
April 30, 1987
Resolution of acquired factor X deficiency and amyloidosis with melphalan and prednisone therapy
J K Camoriano, P R Greipp, G K Bayer, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery
|
October 1, 1985
Gamma heavy-chain disease involving upper airway
D J Blum, J A Doyle, P R Greipp, et al.
The Journal of Experimental Medicine
|
February 1, 1990
Preferential linkage of bcl-2 to immunoglobulin light chain gene in chronic lymphocytic leukemia
M Adachi, A Tefferi, P R Greipp, et al.
Clinical Orthopaedics and Related Research
|
August 1, 1997
Prosthetic hip replacement for pathologic or impending pathologic fractures in myeloma
P J Papagelopoulos, E C Galanis, P R Greipp, et al.
Blood
|
July 1, 1988
Value of beta 2-microglobulin level and plasma cell labeling indices as prognostic factors in patients with newly diagnosed myeloma
P R Greipp, J A Katzmann, W M O'Fallon, et al.
Page
of 18
Search research articles
Search
Showing results (51-60 of 178) with videos related to
Sort By:
Page
of 18
The American Journal of Medicine
|
December 1, 1985
Primary systemic amyloidosis. Comparison of melphalan/prednisone versus colchicine
R A Kyle, P R Greipp, J P Garton, et al.
British Journal of Haematology
|
February 23, 1999
Measurement of apoptosis and proliferation of bone marrow plasma cells in patients with plasma cell proliferative disorders
T E Witzig, M Timm, D Larson, et al.
Cytometry
|
November 1, 1985
A monoclonal antibody reactive with 5-bromo-2-deoxyuridine that does not require DNA denaturation
N J Gonchoroff, P R Greipp, R A Kyle, et al.
British Journal of Haematology
|
June 1, 1994
Detection of peripheral blood plasma cells as a predictor of disease course in patients with smouldering multiple myeloma
T E Witzig, R A Kyle, W M O'Fallon, et al.
Cancer
|
July 1, 1993
Quantitation of circulating peripheral blood plasma cells and their relationship to disease activity in patients with multiple myeloma
T E Witzig, M V Dhodapkar, R A Kyle, et al.
The New England Journal of Medicine
|
April 30, 1987
Resolution of acquired factor X deficiency and amyloidosis with melphalan and prednisone therapy
J K Camoriano, P R Greipp, G K Bayer, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery
|
October 1, 1985
Gamma heavy-chain disease involving upper airway
D J Blum, J A Doyle, P R Greipp, et al.
The Journal of Experimental Medicine
|
February 1, 1990
Preferential linkage of bcl-2 to immunoglobulin light chain gene in chronic lymphocytic leukemia
M Adachi, A Tefferi, P R Greipp, et al.
Clinical Orthopaedics and Related Research
|
August 1, 1997
Prosthetic hip replacement for pathologic or impending pathologic fractures in myeloma
P J Papagelopoulos, E C Galanis, P R Greipp, et al.
Blood
|
July 1, 1988
Value of beta 2-microglobulin level and plasma cell labeling indices as prognostic factors in patients with newly diagnosed myeloma
P R Greipp, J A Katzmann, W M O'Fallon, et al.
Page
of 18